Companies formed

Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.

Over £266 million in external investment has been raised by Oxford University Innovation spinouts since 2000, and five are currently listed on London’s AIM market.

The creation of these new spinout companies also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.

Companies by University of Oxford Department

CCRF

Chemistry

Specialise in applying state-of-the-art mass spectrometry platforms to characterising intact protein assemblies, often referred to as native mass spectrometry.

Incorporated in March 2016

Origin: Oxford University, Chemistry

Contact: James Mallinson

Researches, designs and will market diagnostic tests for the measurement of clinical bio markers that reduce healthcare costs and improve patient outcomes.

Incorporated in June 2016

Origin: Oxford University, Chemistry

Contact: James Mallinson

Computer Sciences

Department of Biochemistry

Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials, crysalins, that are produced through modification of naturally occurring protein building blocks.

Incorporated in June 2007

Origin: Oxford University, Department of Biochemistry

Contact: James Mallinson

Department of Chemistry

At OxSyBio, we are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Our vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.

Professor Bayley’s group have previously demonstrated the ability to print three-dimensional networks comprising tens of thousands of picoliter aqueous droplets forming a cohesive material. These networks can be built in software-controlled geometries using a number of different droplet types, thus enabling them to perform simple cell-like functions and act as ‘tissue-like’ materials. Initial work showed that printed networks were capable of conducting electrical signals along neuron-like pathways by the selective incorporation of membrane proteins, or to fold in a pre-defined manner to assume altered shapes after printing.

OxSyBio is refining and advancing this technology to print more complex networks more rapidly and at a higher resolution. We are also adapting the approach to print living cells inside droplets, which will enable the direct printing of 3D cell networks with many of the characteristics of living tissues.

Incorporated in April 2014

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.

Incorporated in September 2013

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Oxidative Enzymes for the Pulp and Paper Industry.

Incorporated in February 2010

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Oxtox develops medical devices for the detection of specific drugs in the human system.

Incorporated in November 2006

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Oxford Advanced Surfaces develops and commercialises advanced materials and technology solutions leveraging breakthrough surface modification technology.

Incorporated in September 2006

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins.

Incorporated in May 2005

Origin: Oxford University, Department of Chemistry

Contact: James Mallinson

Department of Classics

Develops and manufacturers multispectral digital scanners based upon a patented flatbed scanner design.

Incorporated in September 2011

Origin: Oxford University, Department of Classics

Contact: James Mallinson

Department of Computer Science

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

Incorporated in January 2014

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

Domain-centric intelligent automated data extraction methodology.

Incorporated in February 2015

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

A revolutionary new approach to indoor positioning that combines data from mobile phone sensors with map information such as floor plans, and wifi “maps” where available, to give highly accurate location information without the need for any further hardware.

Incorporated in December 2015

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

SemmleCode is a line of products aimed to help developer teams improve their software quality.

Incorporated in March 2008

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

DiffBlue is a world leader in automated test generation. Their products have been developed with industry partners over the last ten years and replace the manual process of writing tests.

Incorporated in March 2016

Origin: Oxford University, Department of Computer Science

Contact: James Mallinson

Department of Earth Sciences

EKB Technology commercialises a revolutionary Bioprocessing Technology developed for the use of biological systems such as plant and animal cells and microorganisms to modify, produce or purify chemical intermediates.

Incorporated in December 2004

Origin: Oxford University, Department of Earth Sciences

Contact: James Mallinson

Department of Engineering Science

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Incorporated in August 2015

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Offering the most accurate assessment of running biomechanics that modern science is able to provide.

Incorporated in December 2012

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

The OxEML system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound.

Incorporated in October 2015

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.

Incorporated in September 2015

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.

Incorporated in April 2015

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Developing tiny metallic mesh tube devices to treat patients suffering from brain aneurysms

Incorporated in December 2015

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

A software that uses advanced algorithms and techniques to solve problems

Incorporated in February 2016

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Kepler Energy Limited develops a second-generation tidal turbine, which has the potential to harness tidal energy more efficiently and cheaply, using a device which is simpler, more robust and more scalable than current designs.

Incorporated in October 2010

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Oxford Electromagnetic Solutions - smart asset management through underground network visibility.

Incorporated in June 2010

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

YASA Motors manufactures a highly differentiated advanced axial flux motor and generator based on its proprietary Yokeless And Segmented Armature (YASA™) technology.

Incorporated in August 2009

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Navetas is a UK based technology company delivering cloud-based energy monitoring and smart data analytics for the connected home.

Incorporated in November 2008

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Aurox was established to research, develop, manufacture and commercially exploit products in the field of confocal microscopy and automated pathology slide scanners.

Incorporated in July 2006

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Particle Therapeutics is a drug delivery company developing innovative particle formulation and drug delivery technologies to improve the efficacy and administration of a range of pharmaceuticals.

Incorporated in June 2006

Origin: Oxford University, Department of Engineering Science

Contact: James Mallinson

Department of Materials

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Incorporated in April 2014

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Using phase change materials for smart glazing and displays.

Incorporated in November 2015

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level.

Incorporated in October 2011

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Tissue expander solutions for the primary use in reconstructive and dental surgery.

Incorporated in July 2011

Origin: Oxford University, Department of Materials

Contact: James Mallinson

Department of Mathematics/Oxford e-Research Centre

Incorporated in March 2009

Origin: Oxford University, Department of Mathematics/Oxford e-Research Centre

Contact: James Mallinson

Department of Organic Chemistry

Robust, networked sensors for oilfield machinery, drilling and metering.

Incorporated in June 2005

Origin: Oxford University, Department of Organic Chemistry

Contact: James Mallinson

Summit Therapeutics is an international biopharmaceutical company focussed on the discovery and development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile.

Incorporated in February 2003

Origin: Oxford University, Department of Organic Chemistry

Contact: James Mallinson

Department of Pathology

Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression.

Incorporated in June 2007

Origin: Oxford University, Department of Pathology

Contact: James Mallinson

BioAnalab offers a contract testing service to the biopharmaceutical industry for the rapidly growing area of therapeutic monoclonal antibodies, with a longer-term strategy to develop diagnostics to measure levels of monoclonal antibodies and their immune response. In July 2009, BioAnaLab was acquired by Millipore Corp.

Incorporated in November 2002

Origin: Oxford University, Department of Pathology

Contact: James Mallinson

Department of Pharmacology

Celleron is an oncology healthcare company that has developed biomarkers using epigenetic techniques that match drugs to responsive disease.

Incorporated in November 2005

Origin: Oxford University, Department of Pharmacology

Contact: James Mallinson

G-Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption. These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them, offering personalised treatment to the 'smoker' which significantly increases their chances of quitting.

Incorporated in June 2004

Origin: Oxford University, Department of Pharmacology

Contact: James Mallinson

Department of Physical and Theoretical Chemistry

Oxford Medical Diagnostics develops and supplies breath analysis technologies for rapid, accurate, and low-cost monitoring of diseases and metabolic functions.

Incorporated in June 2004

Origin: Oxford University, Department of Physical and Theoretical Chemistry

Contact: James Mallinson

Department of Physics

Oxford PV are developing new photovoltaic cells that will provide a sustainable solar energy source.

Incorporated in November 2010

Origin: Oxford University, Department of Physics

Contact: James Mallinson

Department of Surgical Sciences

A biotechnology company formed to research and develop novel medicines from natural sources for the treatment of immune-mediated and inflammatory diseases.

Incorporated in November 2010

Origin: Oxford University, Department of Surgical Sciences

Contact: James Mallinson

Department of Zoology

AnDy marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Incorporated in April 2015

Origin: Oxford University, Department of Zoology

Contact: James Mallinson

Engineering

Geography, Maths, Computer Sciences, Engineering

Maritime trade and transport simulation.

Incorporated in February 2017

Origin: Oxford University, Geography, Maths, Computer Sciences, Engineering

Contact: Paul Ashley

Institute of Biomedical Engineering

OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.

Incorporated in January 2014

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

Revolutionary healthcare technology that measures medical vital signs without physical contact.

Incorporated in August 2012

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality, more consistent ultrasound imaging service for their patients.

Incorporated in July 2012

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

Using leading edge human biomimetic platforms to test and develop therapeutics for serious human diseases.

Incorporated in July 2009

Origin: Oxford University, Institute of Biomedical Engineering

Contact: James Mallinson

Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences

The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation. The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs.

Incorporated in November 2008

Origin: Oxford University, Institute of Biomedical Engineering/Nuffield Department of Surgical Sciences

Contact: James Mallinson

Ludwig Institute

Neuroscience

EvOx Therapeutics harnesses the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Incorporated in April 2016

Origin: Oxford University, Neuroscience

Contact: James Mallinson

The OxSight ‘SmartSpecs’ help sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Incorporated in June 2016

Origin: Oxford University, Neuroscience

Contact: James Mallinson

Nuffield Department of Clinical Neurosciences

A private biopharmaceutical company focused on the development of therapies for retinal dystrophies.

Incorporated in January 2014

Origin: Oxford University, Nuffield Department of Clinical Neurosciences

Contact: James Mallinson

Nuffield Division of Clinical and Laboratory Sciences

ClinOx offers clients knowledge and expertise in the development, placement, conduct and analysis of early phase oncology clinical trials, with particular emphasis on pharmacokinetic and mechanistic endpoints.

Incorporated in June 2007

Origin: Oxford University, Nuffield Division of Clinical and Laboratory Sciences

Contact: James Mallinson

Pharmacology

Physics

Oxford Nanoimaging’s microscope, the Nanoimager, is a single-molecule fluorescence microscope.
It is about 30 times smaller and significantly less expensive than current super-resolution microscopes and will be manufactured in the UK.

Incorporated in May 2016

Origin: Oxford University, Physics

Contact: James Mallinson

Developing superconducting circuit quantum computing.

Incorporated in June 2017

Origin: Oxford University, Physics

Contact: James Mallinson

Radcliffe Department of Medicine

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Incorporated in July 2015

Origin: Oxford University, Radcliffe Department of Medicine

Contact: Carolyn Porter

Sir William Dunn School of Pathology

Data discovery software to manage and sort collections of images and data visually

Incorporated in January 2016

Origin: Oxford University, Sir William Dunn School of Pathology

Contact: James Mallinson

Weatherall Institute of Molecular Medicine

Cellular immunity vaccines.

Incorporated in September 2012

Origin: Oxford University, Weatherall Institute of Molecular Medicine

Contact: James Mallinson

Wellcome Trust Centre for Human Genetics

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

Incorporated in March 2014

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Contact: James Mallinson

Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs. Surface Therapeutics was acquired by Serentis Inc in September 2007.

Incorporated in November 2004

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Contact: James Mallinson

A biotherapeutics company, established to exploit the work in Viral Hepatitis undertaken at Imperial College, London and at Oxford University through the Wellcome Trust Centre for Human Genetics.

Incorporated in July 2003

Origin: Oxford University, Wellcome Trust Centre for Human Genetics

Contact: James Mallinson

Search

Ready to get in touch?

Contact Us
Search
© Oxford University Innovation